HopeStage
Back to all studies
RecruitingISRCTN23496771

Metformin versus placebo to limit weight gain with antipsychotic treatment in severe mental health conditions

About this title

Metformin for Antipsychotic-Induced Weight Gain in People with Severe Mental Illness

Read the official source — ISRCTN23496771
Research studyAges 18–100Pakistan
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 100 years.

Listed locations
Pakistan

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
University of York
Sponsor type
University
Study type
Other
Intervention type
Other / unclear
Locations
Pakistan
Age range
From 18 Years to 100 Years
Official registry ID
ISRCTN23496771
Official title
Show the full official title

The effectiveness of Metformin for reducing weight gain experienced by people with severe mental health problems in South Asia

Recruitment & locations

Currently recruiting

Pakistan

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of York, a university.

Who can participate?

Listed age limits: 18 years to 100 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies